Everest Medicines Limited (1952.HK) HKSE

44.56

-0.74(-1.63%)

Updated at December 05 11:58AM

Currency In HKD

Valuation

Market Cap14.59B
Enterprise Value14.28B
P/E Ratio-19.97
PEG Ratio-0.87
Price/Sales Ratio16.78
Price/Book Ratio3.35
Enterprise/Revenue16.09
Enterprise/EBITDA-49.5

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin-0.77
Operating Margin-0.9

Management Effectiveness

Return On Assets-0.13
Return On Equity-0.16

Income Statement

Revenue706.68M
Revenue/Share2.62
Gross Profit528.89M
EBITDA-670.04M
Net Income-1.04B
Diluted EPS-3.24

Balance Sheet

Total Cash1.59B
Total Cash/Share4.87
Total Debt708.72M
Total Debt/Equity0.18
Current Ratio5.46
Book Value Per Share12.07

Price History

52-Week Change-4.01
52-Week High77.55
52-Week Low36.3
Moving Average 50 Days49.83
Moving Average 200 Days55.01

Statistics

Average Volume3.65M
Shares Outstanding353.25M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A